Products & Services · Year Eight

Multi-line and other specialty — Year Eight

Arch Capital Group Multi-line and other specialty — Year Eight increased by 27.3% to 1.4% in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 27.3%, from 1.1% to 1.4%. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ4 2018
Last reportedQ4 2025

How to read this metric

An upward trend reflects sustained market relevance and effective risk management, whereas a decline could signal market saturation or increased loss ratios.

Detailed definition

This metric measures the financial performance of the multi-line and specialty insurance segment during the eighth year...

Peer comparison

Comparable to multi-year segment growth metrics reported by large-cap diversified insurance and reinsurance firms.

Metric ID: acgl_segment_multi_line_and_other_specialty_year_eight

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value0.7%0.4%0.4%1.1%1.4%
QoQ Change-42.9%+0.0%+175.0%+27.3%
YoY Change-42.9%+0.0%+175.0%+27.3%
Range0.4%1.4%
CAGR+100.0%
Avg YoY Growth+39.9%
Median YoY Growth+13.6%
Current Streak3 quarters growth

Frequently Asked Questions

What is Arch Capital Group's multi-line and other specialty — year eight?
Arch Capital Group (ACGL) reported multi-line and other specialty — year eight of 1.4% in Q4 2025.
How has Arch Capital Group's multi-line and other specialty — year eight changed year-over-year?
Arch Capital Group's multi-line and other specialty — year eight increased by 27.3% year-over-year, from 1.1% to 1.4%.
What does multi-line and other specialty — year eight mean?
The financial performance of the multi-line and specialty insurance segment in the eighth year of the reporting period.